Progression and metastasis of lung cancer
HH Popper - Cancer and Metastasis Reviews, 2016 - Springer
… by a tumor suppressor gene, frequently lost in lung cancer, RBM5 (RNA-binding motif protein
5; … correlate positively with lymph node metastasis in lung cancer patients [47]. Two other …
5; … correlate positively with lymph node metastasis in lung cancer patients [47]. Two other …
[PDF][PDF] Prognosis of different types of non-small cell lung cancer progression: current state and perspectives
AA Schegoleva, AA Khozyainova… - Cell Physiol …, 2021 - cellphysiolbiochem.com
… of local and distant failure in resected lung cancer: implications for reported rates of local …
recurrence and second primary lung cancer in early-stage lung cancer survivors followed with …
recurrence and second primary lung cancer in early-stage lung cancer survivors followed with …
Clinical significance of post‐progression survival in lung cancer
H Imai, K Kaira, K Minato - Thoracic Cancer, 2017 - Wiley Online Library
… lung cancer, whereas PFS is only moderately associated with OS. Therefore, subsequent
treatment after disease progression … that even in advanced lung cancer, PPS, rather than PFS, …
treatment after disease progression … that even in advanced lung cancer, PPS, rather than PFS, …
[HTML][HTML] Immunotherapy beyond progression in patients with advanced non-small cell lung cancer
X Ge, Z Zhang, S Zhang, F Yuan, F Zhang… - … lung cancer research, 2020 - ncbi.nlm.nih.gov
… In 2018, lung cancer was responsible for approximately 1.8 million deaths globally, with 2.1
… subtypes of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer. …
… subtypes of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer. …
[HTML][HTML] Patient-reported outcome measures used in routine care predict for survival at disease progression in patients with advanced lung cancer
… PRO measures used in routine care provide clinicians with relevant prognostic information
about patients with lung cancer at disease progression. These results show the potential …
about patients with lung cancer at disease progression. These results show the potential …
Lung cancer progression and metastasis from the prognostic point of view
K Inamura, Y Ishikawa - Clinical & experimental metastasis, 2010 - Springer
… for p-Stage I lung cancer patients is good as compared with the literature. Whereas the
reported 5-year survival for p-Stage I patients with non-small cell lung cancer is about 60% [1], it …
reported 5-year survival for p-Stage I patients with non-small cell lung cancer is about 60% [1], it …
Rapid disease progression with delay in treatment of non–small-cell lung cancer
N Mohammed, LL Kestin, IS Grills, M Battu… - International Journal of …, 2011 - Elsevier
… We found that clinical progression of disease occurred in 13% of patients at only 4 weeks.
Clinical progression rates at 8 and 16 weeks were 31% and 46%, respectively. The likelihood …
Clinical progression rates at 8 and 16 weeks were 31% and 46%, respectively. The likelihood …
Clinical detection of lung cancer progression markers
MS Tockman - Journal of Cellular Biochemistry, 1996 - Wiley Online Library
… morphologic progression seen in archived sputum cells as the paradigm of neoplastic
development in the lung. Although the NCI collaborative trials had shown that this progression is …
development in the lung. Although the NCI collaborative trials had shown that this progression is …
Metabolic tumor burden predicts for disease progression and death in lung cancer
P Lee, DK Weerasuriya, PW Lavori, A Quon… - International Journal of …, 2007 - Elsevier
… Patients and Methods We identified 19 patients with lung cancer who had staging PET-CT
scans before any therapy, and adequate follow-up (complete to time of progression for 18, …
scans before any therapy, and adequate follow-up (complete to time of progression for 18, …
Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer
W Matsuyama, T Hashiguchi, A Mizoguchi, F Iwami… - Chest, 2000 - Elsevier
… important in predicting the clinical course of lung cancerpatients. In this study, … lung cancer
patients to determine whetherthis parameter might be used to evaluate disease progression. …
patients to determine whetherthis parameter might be used to evaluate disease progression. …
相关搜索
- host side patients with lung cancer
- growth factor patients with lung cancer
- postprogression survival in patients lung cancer
- overall survival in patients lung cancer
- cell lung cancer
- outcome measures lung cancer
- disease progression lung cancer
- metabolic tumor burden lung cancer
- lung cancer metastasis
- non-small cell lung cancer patients
- molecular biology of lung cancer
- systematic review lung cancer
- life in lung cancer patients
- non-small cell lung cancer overall survival
- clinical significance lung cancer
- prognostic value lung cancer